Our study demonstrated the SLE duration at conception, LN, history of therapeutic abortion, C3, lupus anticoagulant, IgG, serum ALB, CRP, PRO, HDL, and HCQ were identified as potential correlates of fetal loss in pregnant women with SLE with mild disease severity. This evidence concerns the gene C3 and systemic lupus erythematosus.